Search research articles
Contact Us
Filters
Showing results (501-510 of 792) with videos related to
Page
of 80
Sort By:
NIDA Research Monograph
|
January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligands
R B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology
|
February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands
R B Rothman, A Reid, A Mahboubi, et al.
The Journal of Endocrinology
|
July 1, 1989
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes
D J Carr, B R DeCosta, C H Kim, et al.
Biology of the Neonate
|
January 1, 1989
A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period
D W Seccombe, M R Pudek, K H Humphries, et al.
Archives of Dermatology
|
August 1, 1993
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers
J M Wood, P E Evans, K U Schallreuter, et al.
Steroids
|
July 12, 2005
A concise method for the preparation of deuterium-labeled cortisone: synthesis of [6,7-2H]cortisone
Agnieszka Sulima, Thomas E Prisinzano, Thomas Spande, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1986
Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study
Y Wang, M Palmer, R Freedman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 22, 2025
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?
M E Jacobson, C M Boesjes, M S de Bruin-Weller, et al.
Peptides
|
November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site
R B Rothman, A Mahboubi, V Bykov, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 15, 2000
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole
A Coop, A E Jacobson, M D Aceto, et al.
Page
of 80
Search research articles
Search
Showing results (501-510 of 792) with videos related to
Sort By:
Page
of 80
NIDA Research Monograph
|
January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligands
R B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology
|
February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands
R B Rothman, A Reid, A Mahboubi, et al.
The Journal of Endocrinology
|
July 1, 1989
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes
D J Carr, B R DeCosta, C H Kim, et al.
Biology of the Neonate
|
January 1, 1989
A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period
D W Seccombe, M R Pudek, K H Humphries, et al.
Archives of Dermatology
|
August 1, 1993
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers
J M Wood, P E Evans, K U Schallreuter, et al.
Steroids
|
July 12, 2005
A concise method for the preparation of deuterium-labeled cortisone: synthesis of [6,7-2H]cortisone
Agnieszka Sulima, Thomas E Prisinzano, Thomas Spande, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1986
Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study
Y Wang, M Palmer, R Freedman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 22, 2025
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?
M E Jacobson, C M Boesjes, M S de Bruin-Weller, et al.
Peptides
|
November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site
R B Rothman, A Mahboubi, V Bykov, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 15, 2000
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole
A Coop, A E Jacobson, M D Aceto, et al.
Page
of 80